MicroPort EverPace™ PulseMagic™ TrueForce® PFA Catheter
Cardiac Arrhythmias
NMPA ApprovedApproved
Key Facts
About MicroPort
MicroPort is a mission-driven global medical device company with the goal of providing trustworthy, universal access to state-of-the-art solutions that prolong and reshape lives. Founded in 1998, it has grown into a diversified powerhouse with eight core business units, achieving significant regulatory milestones and commercial successes, including over 10 million coronary stent systems shipped and over 100 installations of its Toumai® surgical robot. Its strategy is built on a federated model of focused subsidiaries, a global R&D and manufacturing footprint, and a proprietary industrial ecosystem designed to foster innovation and streamline market access.
View full company profileTherapeutic Areas
Other Cardiac Arrhythmias Drugs
| Drug | Company | Phase |
|---|---|---|
| nsPFA Navigation (Pulse Biosciences) | CardioNXT | Pre-clinical |
| Platform Extension (e.g., Cardioneuroablation) | inHEART | Development/Exploration |
| Cardiac Arrhythmia Program | Current Surgical | Research |
| Aveir DR Dual-Chamber Leadless Pacemaker | Abbott | Clinical Investigation |